Rubicon Research Limited (RUBICON) — Announcement

· NSE Neutral
📢 Key Event
Committee approves issuance of 1,49,158 employee stock options
🔄 What Changed
Paid-up capital increased to INR 16,55,31,908
💡 Investor Takeaway
The share issuance expands the company’s equity base and may dilute existing shareholders.

Rubicon Research Limited announced on July 20, 2026, that its Nomination and Remuneration Committee approved the allotment of 1,49,158 fully paid-up equity shares of INR 1 each under the Employee Stock Option Scheme 2022, increasing the paid-up capital to INR 16,55,31,908. This issuance reflects the company’s ongoing use of equity incentives to reward employees and aligns with regulatory disclosure requirements.

📄 View Original Announcement (PDF)

About Rubicon Research Limited (RUBICON)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,864.53 Cr

View full RUBICON stock details →

📡 Get AI alerts when RUBICON files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RUBICON — Free

📊 More RUBICON filings

See all RUBICON filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when RUBICON files new disclosures

Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RUBICON — Free

Free account · 2 AI queries/day